MEF2C and acute lymphoblastic leukemia: Using gene expression profiling of pediatric patients with T-ALL, we previously identified 4 biological T-ALL subtypes, among which was an immature T-ALL subtype with MEF2C-activating rearrangements in some of the patients (5), in extension of previous observations by others (2, 3).